Deciphering regulatory principles of proteasome heterogeneity and the degradation landscape in cancer

Project Information

Cancer_Deg

Grant agreement ID: 101045613

DOI

10.3030/101045613

EC signature date 25 July 2022

Start date 1 August 2022

End date 31 July 2028

Funded under

• European Research Council (ERC)

Total cost

€ 1 978 750,00

EU contribution

€ 1 978 750,00

Coordinated by

WEIZMANN INSTITUTE OF SCIENCE
Israel

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Publications

Peer reviewed articles (1)

The proteasome regulator PSME4 modulates proteasome activity and antigen diversity to abrogate antitumor immunity in NSCLC

Author(s): Aaron Javitt; Merav D. Shmueli; Matthias P. Kramer; Aleksandra A. Kolodziejczyk; Ivan J. Cohen; Lihi Radomir; Daoud Sheban; Iris Kamer; Kevin Litchfield; Elizabeta Bab-Dinitz; Oranit Zadok; Vanessa Neiens; Adi Ulman; Hila Wolf-Levy; Avital Eisenberg-Lerner; Assaf Kacen; Michal Alon; Ana Toste Rêgo; Elvira Stacher-Priehse; Michael Lindner; Ina Koch; Jair Bar; Charles Swanton; Yardena Samuels; Yishai Levin; Paula C. A. da Fonseca; Eran Elinav; Nir Friedman; Silke Meiners; Yifat Merbl
Published in: Nature Cancer, 2023, ISSN 2662-1347
Publisher: Springer Science and Business Media LLC
DOI: 10.1038/s43018-023-00557-4